clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Disruption of Asxl1 Gene Improves Tumor Control in Immunotherapy
Coronavirus
Long COVID Linked to Persistent Infection
Informatics
AI-Powered Chatbots Unreliable for Patient Drug Information
News & Features
New Therapeutic Strategy Offers Hope for Treating Aggressive Triple-Negative Breast Cancer
Coronavirus
COVID-19 Raises Risk of Heart Attack, Stroke, and Death up to…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Sarepta Wins Key Label Expansion for DMD Gene Therapy, in Wake of Pfizer Failure
Sarepta Therapeutics
News & Features
Sarepta Wins Key Label Expansion for DMD Gene Therapy, in Wake of Pfizer Failure
June 21, 2024
0
News & Features
Sarepta’s Gene Therapy for DMD Misses on Key Endpoint in Pivotal Trial
October 31, 2023
0
News & Features
Sarepta Gets Adcomm Backing for Duchenne Gene Therapy
May 15, 2023
0
Informatics
Real-World Data: The Secret Sauce for Rare Disease Research?
Malorye Branca
February 10, 2023
0
News & Features
Sarepta and GenEdit Ink $57M Deal for Non-Viral Gene Delivery
February 2, 2022
0
News & Features
Epigenetic Editing Startup Chroma Medicine Launches With $125M Funding
November 18, 2021
0
News & Features
Sarepta Launches Gene Therapy Trial for Duchenne Muscular Dystrophy
October 7, 2021
0
News & Features
AI Can Make Gene Therapy Design More Effective
February 12, 2021
0
Related Content
Blood Test Predicts Outcomes in Newly Diagnosed Metastatic Prostate Cancer
The End of the Beginning for Cell and Gene Therapy
AviadoBio and Astellas Ink Potential $2.5B+ Deal for Frontotemporal Dementia Candidate
In Conversation with Frank Gleeson
Inside Precision Medicine